MOSCOW – German company BioNTech plans to produce two billion doses of coronavirus vaccine this year due to increased global demand, reported the Sputnik news agency.
“To respond to an increased global demand, we plan to manufacture two billion doses of our Covid-19 vaccine in 2021 by expanding the previously expected output of 1.3 billion doses by more than 50%,” BioNTech said in a statement.
“We are on track to scale up our manufacturing capacities,” it added. – Bernama, February 2, 2021
